The shares of Ashland Global Holdings Inc. (NYSE:ASH) has been pegged with a rating of Hold by Jefferies in its latest research note that was published on March 23, 2020. Jefferies wasn’t the only research firm that published a report of Ashland Global Holdings Inc., with other equities research analysts also giving their opinion on the stock. JP Morgan advised investors in its research note published on January 29, 2020, to Underweight the ASH stock while also putting a $68 price target. The stock had earned Market Perform rating from BMO Capital Markets Markets when it published its report on November 20, 2019. Monness Crespi & Hardt was of a view that ASH is Buy in its latest report on October 14, 2019. JP Morgan thinks that ASH is worth Neutral rating. This was contained in the firm’s report on June 14, 2019 in which the stock’s price target was also moved to 82.
Amongst the analysts that rated the stock, 1 have recommended investors to sell it, 2 believe it has the potential for further growth, thus rating it as Hold while 8 advised investors to purchase the stock. The consensus currently stands at a Overweight while its average price target is $73.10. The price of the stock the last time has raised by 20.42% from its 52-Week high price while it is -42.78% than its 52-Week low price. A look at the stock’s other technical shows that its 14-day RSI now stands at 35.41.
The shares of the company added by 10.19% during the trading session on Wednesday, reaching a low of $41.86 while ending the day at $46.82. During the trading session, a total of 1.09 million shares were traded which represents a -63.05% decline from the average session volume which is 668390.0 shares. ASH had ended its last session trading at $42.49. Ashland Global Holdings Inc. currently has a market cap of $2.81 billion, while its P/E ratio stands at 21.87, while its P/E earnings growth sits at 3.85, with a beta of 1.47. Ashland Global Holdings Inc. debt-to-equity ratio currently stands at 0.46, while its quick ratio hovers at 1.00 ASH 52-week low price stands at $38.88 while its 52-week high price is $81.82.
The company in its last quarterly report recorded $0.13 earnings per share which is above the predicted by most analysts. The Ashland Global Holdings Inc. generated 157.0 million in revenue during the last quarter. In the second quarter last year, the firm recorded $0.77 earnings per share. Compared to the same quarter last year, the firm’s revenue was down by -538.46%. Ashland Global Holdings Inc. has the potential to record 2.74 EPS for the current fiscal year, according to equities analysts.
It started the day trading at $0.51 and traded between $0.4499 and $0.45 throughout the trading session.
A look at its technical shows that GHSI’s 50-day SMA is 0.3470 while its 200-day SMA stands at 0.5447. The stock has a high of $4.00 for the year while the low is $0.17. The stock, however, witnessed a rise in its short on 03/13/20. Compared to previous close which recorded 1585163.72 shorted shares, the short percentage went lower by -50.83%, as 779,425 ASH shares were shorted. At the moment, only 2.16% of Guardion Health Sciences Inc. shares were sold short. The company’s average trading volume currently stands at 11.12M shares, which means that the short-interest ratio is just 0.14 days. Over the past seven days, the company moved, with its shift of 11.11%. Looking further, the stock has raised 131.72% over the past 90 days while it lost -43.25% over the last six months.
Barclays Capital, Inc. meanwhile bought more GHSI shares in the recently filed quarter, changing its stake to $88,969 worth of shares.
Similarly, Virtu Financial BD LLC increased its Guardion Health Sciences Inc. shares by 310.31% during the recently filed quarter. After buying 139,961 shares in the last quarter, the firm now controls 105,850 shares of Guardion Health Sciences Inc. which are valued at $59,343. In the same vein, UBS Securities LLC increased its Guardion Health Sciences Inc. shares by during the most recent reported quarter. The firm bought 84,241 shares during the quarter which increased its stakes to 92,543 shares and is now valued at $39,238. Following these latest developments, around 1.80% of Guardion Health Sciences Inc. stocks are owned by institutional investors and hedge funds.